🇺🇸 FDA
Pipeline program

TI-0010

TI-0010-10102

Phase 1 mab active

Quick answer

TI-0010 for COVID-19 is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
COVID-19
Phase
Phase 1
Modality
mab
Status
active

Clinical trials